Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-17-000804

Director sold 3,150 shares at an average $18.52 ($58,345)

From the SEC's structured data for this filing

Trades in this filing

EMSTER KURT VON · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-08-18 Sale : show line 1 in the form −1,900 $18.53 $35,207 2,081,390 I
2017-08-21 Sale : show line 2 in the form −1,250 $18.51 $23,138 2,080,140 I
Open-market sales · 3,150 sh · avg $18.52 · $58,345
Loading xslF345X03/vonemster_fm4aug182017.xml…